Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 41, 2011 - Issue 11
581
Views
62
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

CYP2D plays a major role in berberine metabolism in liver of mice and humans

, , , , &
Pages 996-1005 | Received 17 May 2011, Accepted 13 Jun 2011, Published online: 25 Jul 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Yan Zhu, Li Chen, Yuqi He, Lin Qin, Daopeng Tan, Zhaojun Bai, Yu Song & Yu-He Wang. (2023) The alteration of drug metabolism enzymes and pharmacokinetic parameters in nonalcoholic fatty liver disease: current animal models and clinical practice. Drug Metabolism Reviews 55:3, pages 163-180.
Read now
Ajay Kumar Sharma, Vijay Kumar Kapoor & Gurjot Kaur. (2022) Herb–drug interactions: a mechanistic approach. Drug and Chemical Toxicology 45:2, pages 594-603.
Read now
Weibin Xiao, Zhirong Deng, Chongfa Lai, Haoyang Lu, Mutu Huang, Yuguan Wen & Lei Shi. (2021) Inhibitory effect of ketoconazole, quinidine and 1-aminobenzotriazole on pharmacokinetics of l-tetrahydropalmatine and its metabolite in rats. Xenobiotica 51:4, pages 447-454.
Read now
Kun Wang, Xinchi Feng, Liwei Chai, Shijie Cao & Feng Qiu. (2017) The metabolism of berberine and its contribution to the pharmacological effects. Drug Metabolism Reviews 49:2, pages 139-157.
Read now
Yan Li, Hongjie Wang, Nan Si, Wei Ren, Lingyu Han, Shaokun Xin, Ran Zuo, Xiaolu Wei, Jian Yang, Haiyu Zhao & Baolin Bian. (2015) Metabolic profiling analysis of berberine, palmatine, jatrorrhizine, coptisine and epiberberine in zebrafish by ultra-high performance liquid chromatography coupled with LTQ Orbitrap mass spectrometer. Xenobiotica 45:4, pages 302-311.
Read now
Sang Yoon Lee, Himchan Jang, Ji-Yoon Lee, Jin Yeul Ma, Soo Jin Oh & Sang Kyum Kim. (2015) Inhibitory effects of Hwang-Ryun-Hae-Dok-Tang on cytochrome P450 in human liver microsomes. Xenobiotica 45:2, pages 131-138.
Read now

Articles from other publishers (56)

Matheus Nunes da Rocha, Márcia Machado Marinho, Hélcio Silva dos Santos, Emmanuel Silva Marinho, Jonas Ildefonso Junior, Janini Filgueira Rosas & Henrique Douglas Melo Coutinho. (2023) Structure-based virtual screening of new antitumor natural berberines: Bioactivity against pancreas cancer by HIF1 inhibition effect. Journal of Molecular Structure 1294, pages 136508.
Crossref
Yajie Cai, Qiaoning Yang, Yanqiao Yu, Furong Yang, Ruina Bai & Xiaodi Fan. (2023) Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review. Frontiers in Pharmacology 14.
Crossref
Célia Marques, Maria Helena Fernandes & Sofia A. Costa Lima. (2023) Elucidating Berberine’s Therapeutic and Photosensitizer Potential through Nanomedicine Tools. Pharmaceutics 15:9, pages 2282.
Crossref
Qin Li, Zihan Chen, Jianrong Zhang, Qiuying Yan, Li Liu, Dongxin Tang, Liu Li, Jinge Zhang, Cheng Hu, Jiayi Ma, Haibo Cheng, An Kang & Dongdong Sun. (2023) The colonic metabolism differences of main alkaloids in normal and colitis mice treated with Coptis chinensis Franch. and Sophora flavescens Ait. herbal pair using liquid chromatography‐high resolution mass spectrometry method combined with chemometrics . Journal of Separation Science 46:14.
Crossref
Micaela Paula Del Gaudio, Scheila Iria Kraus, Tayza Martins Melzer, Pamela Soledad Bustos & María Gabriela Ortega. (2023) Antinociceptive effect and identification of berberine alkaloid in Berberis ruscifolia extracts. Journal of Ethnopharmacology 305, pages 116066.
Crossref
Indah Purwaningsih, Iman Permana Maksum, Dadan Sumiarsa & Sriwidodo Sriwidodo. (2023) A Review of Fibraurea tinctoria and Its Component, Berberine, as an Antidiabetic and Antioxidant. Molecules 28:3, pages 1294.
Crossref
Xiaofang Guo, Xiwen Xiong, Lijun Zhao, Genshen Zhong & Xiaofei Zhu. 2023. Anti-Aging Pharmacology. Anti-Aging Pharmacology 305 327 .
Filip Vlavcheski, Eric J. O’Neill, Filip Gagacev & Evangelia Tsiani. (2022) Effects of Berberine against Pancreatitis and Pancreatic Cancer. Molecules 27:23, pages 8630.
Crossref
Yavuz Yagiz, Gary P. Wang & Liwei Gu. (2022) Emulsification by vitamin E TPGS or Quillaja extract enhanced absorption of berberine without affecting its metabolism in humans. Food & Function 13:23, pages 12135-12143.
Crossref
Alessandro Colletti, Andrea Fratter, Marzia Pellizzato & Giancarlo Cravotto. (2022) Nutraceutical Approaches to Dyslipidaemia: The Main Formulative Issues Preventing Efficacy. Nutrients 14:22, pages 4769.
Crossref
Arian Khoshandam, Mohsen Imenshahidi & Hossein Hosseinzadeh. (2022) Pharmacokinetic of berberine, the main constituent of Berberis vulgaris L.: A comprehensive review . Phytotherapy Research 36:11, pages 4063-4079.
Crossref
Zhuowei Huang & Xiaolan Liu. (2022) Network Pharmacology and Molecular Docking Analysis on Targets and Mechanisms of Berberine in Atypical Antipsychotic-Induced Metabolic Syndrome. Natural Product Communications 17:10, pages 1934578X2211291.
Crossref
Xiaomei Liu, Wenfang Li, Han Zhang, Xiaoming Wang, Yuhong Huang, Yuhong Li & Guixiang Pan. (2022) Biodistribution and pharmacokinetic profile of berberine and its metabolites in hepatocytes. Phytomedicine 104, pages 154288.
Crossref
Shuo Wang, Tao Zhang, Xiaoyan Liu, Zheng Yang, Ludi Li, Danping Shan, Yadong Gao, Yingzi Li, Yanying Li, Youbo Zhang & Qi Wang. (2022) Toxicity and toxicokinetics of the ethanol extract of Zuojin formula. BMC Complementary Medicine and Therapies 22:1.
Crossref
Xi Jiang, Zhongxiu Jiang, Min Jiang & Yan Sun. (2022) Berberine as a Potential Agent for the Treatment of Colorectal Cancer. Frontiers in Medicine 9.
Crossref
Whitney L. Garcia, Carson J. Miller, Gerard X. Lomas, Kari A. Gaither, Kimberly J. Tyrrell, Jordan N. Smith, Kristoffer R. Brandvold & Aaron T. Wright. (2022) Profiling How the Gut Microbiome Modulates Host Xenobiotic Metabolism in Response to Benzo[ a ]pyrene and 1-Nitropyrene Exposure . Chemical Research in Toxicology 35:4, pages 585-596.
Crossref
Jeffry Adiwidjaja, Alan V. Boddy & Andrew J. McLachlan. (2022) Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib. European Journal of Clinical Pharmacology 78:4, pages 597-611.
Crossref
Jose M. Prieto & Guillermo R. Schinella. (2022) Anti-Inflammatory and Antioxidant Chinese Herbal Medicines: Links between Traditional Characters and the Skin Lipoperoxidation “Western” Model. Antioxidants 11:4, pages 611.
Crossref
Yitong Liu. (2022) In silico evaluation of pharmacokinetics and acute toxicity of withanolides in Ashawagandha. Phytochemistry Letters 47, pages 130-135.
Crossref
Mensura Sied Filli, Ahmed Abdalla Ibrahim, Samuel Kesse, Md Aquib, Kofi Oti Boakye-Yiadom, Muhammad Asim Farooq, Faisal Raza, Yubin Zhang & Bo Wang. (2022) Synthetic berberine derivatives as potential new drugs. Brazilian Journal of Pharmaceutical Sciences 58.
Crossref
Mirko Marino, Claudio Gardana, Antonio Scialpi, Giuseppe Giorgini, Paolo Simonetti & Cristian Del Bo’. (2021) An in vitro approach to study the absorption of a new oral formulation of berberine. PharmaNutrition 18, pages 100279.
Crossref
Siva Nageswara Rao Gajula, Megha Sajakumar Pillai, Gananadhamu Samanthula & Rajesh Sonti. (2021) Cytochrome P450 enzymes: a review on drug metabolizing enzyme inhibition studies in drug discovery and development. Bioanalysis 13:17, pages 1355-1378.
Crossref
Yunfeng Han, Yunan Xiang, Yi Shi, Xi Tang, Lin Pan, Jie Gao, Ruohong Bi & Xianrong Lai. (2021) Pharmacokinetics and Pharmacological Activities of Berberine in Diabetes Mellitus Treatment. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-15.
Crossref
Yaohui Zhang, Lixiang Wang, Guichen Li & Jianyuan Gao. (2021) Berberine-Albumin Nanoparticles: Preparation, Thermodynamic Study and Evaluation Their Protective Effects Against Oxidative Stress in Primary Neuronal Cells as a Model of Alzheimer’s Disease. Journal of Biomedical Nanotechnology 17:6, pages 1088-1097.
Crossref
Sobhi Gaba, Anjali Saini, Gurpreet Singh & Vikramdeep Monga. (2021) An insight into the medicinal attributes of berberine derivatives: A review. Bioorganic & Medicinal Chemistry 38, pages 116143.
Crossref
Mengting Zhou, Ying Deng, Meichen Liu, Li Liao, Xuyang Dai, Chaocheng Guo, Xingtao Zhao, Linfeng He, Cheng Peng & Yunxia Li. (2021) The pharmacological activity of berberine, a review for liver protection. European Journal of Pharmacology 890, pages 173655.
Crossref
Ling Ye, Jiaxing Zhang, Wei Xiao & Shuwen Liu. (2020) Efficacy and mechanism of actions of natural antimicrobial drugs. Pharmacology & Therapeutics 216, pages 107671.
Crossref
Amrinder Singh, Kaicun Zhao, Celia Bell & Ajit J. Shah. (2020) Effect of berberine on in vitro metabolism of sulfonylureas: A herb–drug interactions study . Rapid Communications in Mass Spectrometry 34:S4.
Crossref
Wei-Jia Kong, Claudio Vernieri, Marco Foiani & Jian-Dong Jiang. (2020) Berberine in the treatment of metabolism-related chronic diseases: A drug cloud (dCloud) effect to target multifactorial disorders. Pharmacology & Therapeutics 209, pages 107496.
Crossref
Solomon Habtemariam. (2020) The Quest to Enhance the Efficacy of Berberine for Type-2 Diabetes and Associated Diseases: Physicochemical Modification Approaches. Biomedicines 8:4, pages 90.
Crossref
Pooja Rathaur & Kaid Johar SR. (2020) Metabolism and Pharmacokinetics of Phytochemicals in the Human Body. Current Drug Metabolism 20:14, pages 1085-1102.
Crossref
Hong-Yu Xu, Chang-Shun Liu, Chuan-Li Huang, Li Chen, Yu-Rong Zheng, Si-Hang Huang & Xiao-Ying Long. (2019) Nanoemulsion improves hypoglycemic efficacy of berberine by overcoming its gastrointestinal challenge. Colloids and Surfaces B: Biointerfaces 181, pages 927-934.
Crossref
Xu Mao, Huimin Zhao, Qian Wang, Hui Li, Lan Yang, Zixia Hu, Fengjiao Zhang, Xiucai Guo, Ying Peng & Jiang Zheng. (2019) Metabolism‐based herb–drug interaction of Corydalis Bungeanae Herba with berberine in vitro and in vivo in rats . Biomedical Chromatography 33:7.
Crossref
Hui-Hui Guo, Chen-Lin Feng, Wen-Xuan Zhang, Zhi-Gang Luo, Hong-Juan Zhang, Ting-Ting Zhang, Chen Ma, Yun Zhan, Rui Li, Song Wu, Zeper Abliz, Cong Li, Xiao-Lin Li, Xiao-Lei Ma, Lu-Lu Wang, Wen-Sheng Zheng, Yan-Xing Han & Jian-Dong Jiang. (2019) Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases. Nature Communications 10:1.
Crossref
Qi Zhao, Jia-Le Zhang & Fei Li. (2018) Application of Metabolomics in the Study of Natural Products. Natural Products and Bioprospecting 8:4, pages 321-334.
Crossref
Bo Jiang, Liyuan Meng, Feng Zhang, Xiaoling Jin & Guiliang Zhang. (2017) Enzyme-inducing effects of berberine on cytochrome P450 1A2 in vitro and in vivo. Life Sciences 189, pages 1-7.
Crossref
Guofeng Wang, Jingyi Jin, Jiakai Zeng, Rong Shi, Yan Dai, Jiasheng Wu, Yuanyuan Li, Tianming Wang & Yueming Ma. (2017) Involvement of P-glycoprotein and multidrug and toxin extrusion protein 1 in hepatic and renal berberine efflux in mice. RSC Advances 7:55, pages 34801-34809.
Crossref
Nimisha Vijayan, T. S. Swapna, G. Seghal Kiran & Sabu Abdulhameed. 2017. Bioresources and Bioprocess in Biotechnology. Bioresources and Bioprocess in Biotechnology 421 443 .
Mohsen Imenshahidi & Hossein Hosseinzadeh. (2016) Berberis Vulgaris and Berberine: An Update Review . Phytotherapy Research 30:11, pages 1745-1764.
Crossref
Chang-Shun Liu, Yu-Rong Zheng, Ying-Feng Zhang & Xiao-Ying Long. (2016) Research progress on berberine with a special focus on its oral bioavailability. Fitoterapia 109, pages 274-282.
Crossref
HAN-MING CUI, QIU-YAN ZHANG, JIA-LONG WANG, JIAN-LONG CHEN, YU-LING ZHANG & XIAO-LIN TONG. (2015) Poor permeability and absorption affect the activity of four alkaloids from Coptis. Molecular Medicine Reports 12:5, pages 7160-7168.
Crossref
Duo Zhi, Pan-Feng Feng, Jia-Liang Sun, Fengfeng Guo, Rui Zhang, Xin Zhao & Bao-Xin Li. (2015) The enhancement of cardiac toxicity by concomitant administration of Berberine and macrolides. European Journal of Pharmaceutical Sciences 76, pages 149-155.
Crossref
Yong Zhao, Bent Håvard Hellum, Aihua Liang & Odd Georg Nilsen. (2015) Inhibitory Mechanisms of Human CYPs by Three Alkaloids Isolated from Traditional Chinese Herbs. Phytotherapy Research 29:6, pages 825-834.
Crossref
Jin Su, Qing Miao, Peipei Miao, Yuanyuan Zhao, Yuanyuan Zhang, Ning Chen, Yujie Zhang & Shuangcheng Ma. (2015) Pharmacokinetics and Brain Distribution and Metabolite Identification of Coptisine, a Protoberberine Alkaloid with Therapeutic Potential for CNS Disorders, in Rats. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 38:10, pages 1518-1528.
Crossref
Songcan Liu, Xinfeng Zhang, Furong Qiu, Ping Miao, Shujiao Shen, Leilei Zhu, Jin Zeng & Jian Jiang. (2015) Metabolic Interaction of the Active Constituents of Coptis chinensis in Human Liver Microsomes . Evidence-Based Complementary and Alternative Medicine 2015, pages 1-5.
Crossref
Han-Ming Cui, Qiu-Yan Zhang, Jia-Long Wang, Jian-Long Chen, Yu-Ling Zhang & Xiao-Lin Tong. (2014) In vitro studies of berberine metabolism and its effect of enzyme induction on HepG2 cells. Journal of Ethnopharmacology 158, pages 388-396.
Crossref
Parham Jabbarzadeh Kaboli, Asmah Rahmat, Patimah Ismail & King-Hwa Ling. (2014) Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer. European Journal of Pharmacology 740, pages 584-595.
Crossref
Chun-Jie Wen, Lan-Xiang Wu, Li-Juan Fu, Dong-Ya Shen, Xue Zhang, Yi-Wen Zhang, Jing Yu & Hong-Hao Zhou. (2014) Preferential Induction of CYP1A1 over CYP1B1 in Human Breast Cancer MCF-7 Cells after Exposure to Berberine. Asian Pacific Journal of Cancer Prevention 15:1, pages 495-499.
Crossref
Andrew Owen & Paul Curley. 2014. Humanized Mice for HIV Research. Humanized Mice for HIV Research 339 360 .
Laura Shane-McWhorter. (2013) Dietary Supplements for Diabetes Are Decidedly Popular: Help Your Patients Decide. Diabetes Spectrum 26:4, pages 259-266.
Crossref
Ying Xue, Jing Xiong, Hai-Li Shi, Yi-Ming Liu, Lin-Sen Qing & Xun Liao. (2013) In vitro metabolic study of Rhizoma coptidis extract using liver microsomes immobilized on magnetic nanoparticles. Analytical and Bioanalytical Chemistry 405:27, pages 8807-8817.
Crossref
Jing‐Yi Ma, Ru Feng, Xiang‐Shan Tan, Chao Ma, Jia‐Wen Shou, Jie Fu, Min Huang, Chi‐Yu He, Shuo‐Nan Chen, Zhen‐Xiong Zhao, Wen‐Yi He, Yan Wang & Jian‐Dong Jiang. (2013) Excretion of Berberine and Its Metabolites in Oral Administration in Rats. Journal of Pharmaceutical Sciences 102:11, pages 4181-4192.
Crossref
Meixia Chen. 2014. Handbook of Metabolic Pathways of Xenobiotics. Handbook of Metabolic Pathways of Xenobiotics 1 5 .
Keon Sung Shin, Hyun Sook Choi, Ting Ting Zhao, Kwang Hoon Suh, Ik Hyun Kwon, Soon Ok Choi & Myung Koo Lee. (2013) Neurotoxic effects of berberine on long-term l-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson’s disease. Archives of Pharmacal Research 36:6, pages 759-767.
Crossref
Ying Guo, Yao Chen, Zhi-rong Tan, Curtis D. Klaassen & Hong-hao Zhou. (2011) Repeated administration of berberine inhibits cytochromes P450 in humans. European Journal of Clinical Pharmacology 68:2, pages 213-217.
Crossref
Ying Guo, Chad Pope, Xingguo Cheng, Honghao Zhou & Curtis D. Klaassen. (2011) Dose–response of berberine on hepatic cytochromes P450 mRNA expression and activities in mice. Journal of Ethnopharmacology 138:1, pages 111-118.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.